Please try another search
WntResearch AB is a Sweden-based company engaged in the translational cancer research. Its aim is to develop anti-metastatic therapies based on an increased understanding of the mechanisms underlying the metastatic process and the evaluation of specific small molecules that can specifically interact with this process. The Company’s programs focus on the role of the Wnt-5a protein in the metastatic process. As of December 31, 2011, the Company had two projects, namely Foxy-5 and Box-5. Foxy-5 is a hexapeptide mimicking the effects of WNT-5a. Box-5 is a peptide antagonizing the effects of Wnt-5a. As of March 31, 2012, the Company’s largest shareholder was Forskarpatent I Syd AB, which held 26.55% shares.
Name | Age | Since | Title |
---|---|---|---|
Christer Nordstedt | 61 | 2022 | Chairman of the board |
Peter Strom | 71 | 2015 | Director |
Gudrun Anstrén | 68 | 2019 | Director |
Janna Sand-Dejmek | 51 | 2020 | Director |
Joachim Gullbo | - | 2023 | Scientific Advisors |
Ramon Salazar | 54 | - | Scientific Advisor |
Andres Cervantes | - | - | Scientific Advisor |
Mats Lindskog | - | 2023 | Member |
Jan B. Vermorken | 79 | - | Scientific Advisor |
Thomas Andersson | 68 | 2007 | Founder, Chief Scientific Officer, Director & Scientific Advisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review